Key Points
- CEO John C.M. Farquhar sold 22,562 Heartflow shares for approximately $638,730 at an average price of $28.31, reducing his stake by 4.92%. The sale was conducted under a pre-arranged Rule 10b5-1 trading plan.
- Heartflow reported quarterly revenue of $52.59 million, up 41.3% year over year, and an adjusted loss of $0.16 per share that beat analyst expectations of a $0.24 loss.
- Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and a $36.57 price target, compared with the stock’s opening price of $29.85.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John C.M. Farquhar sold 22,562 shares of the business's stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $28.31, for a total value of $638,730.22. Following the transaction, the chief executive officer owned 436,280 shares of the company's stock, valued at $12,351,086.80. This represents a 4.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John C.M. Farquhar also recently made the following trade(s):
- On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total value of $626,095.50.
- On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00.
- On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.
Heartflow Stock Performance
Heartflow stock opened at $29.85 on Thursday. Heartflow, Inc. has a one year low of $20.13 and a one year high of $41.22. The company has a 50-day simple moving average of $28.76 and a 200-day simple moving average of $27.70. The firm has a market capitalization of $2.57 billion and a P/E ratio of -9.60.
Heartflow (NASDAQ:HTFL - Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.08. The firm had revenue of $52.59 million during the quarter. The business's quarterly revenue was up 41.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the company. Canaccord Genuity Group cut their price target on Heartflow from $43.00 to $37.00 and set a "buy" rating on the stock in a report on Friday, May 15th. Freedom Capital raised Heartflow to a "strong-buy" rating in a report on Tuesday, June 30th. Stifel Nicolaus set a $40.00 target price on Heartflow in a research report on Wednesday, July 15th. William Blair began coverage on Heartflow in a research note on Monday, May 4th. They set an "outperform" rating on the stock. Finally, Wells Fargo & Company boosted their price target on Heartflow from $35.00 to $37.00 and gave the stock an "overweight" rating in a research report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $36.57.
Check Out Our Latest Analysis on Heartflow
Hedge Funds Weigh In On Heartflow
Several large investors have recently bought and sold shares of HTFL. XXEC Inc. acquired a new stake in shares of Heartflow in the 2nd quarter worth approximately $2,524,764,000. BlackRock Inc. bought a new position in shares of Heartflow in the second quarter valued at approximately $152,502,000. Wellington Management Group LLP acquired a new position in shares of Heartflow during the third quarter valued at approximately $164,263,000. Schusterman Interests LLC bought a new stake in Heartflow during the third quarter worth approximately $65,274,000. Finally, Capricorn Investment Group LLC bought a new stake in Heartflow during the fourth quarter worth approximately $48,178,000.
Heartflow Company Profile
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
